Benchmark Starts Rambus Inc. (RMBS) at Buy
Benchmark initiates coverage on Rambus Inc. (NASDAQ: RMBS) with a Buy rating and a price target of $16.00.
Analyst Gary Mobley said, "Our investment thesis hinges on our belief Rambus will continue to forge deeper relationships with leading memory suppliers and system-on-chip companies. In essence, we believe Rambus will continue to shed its reputation as a patent troll and will increasingly engage with customers as a collaborative design, IP company, similar to ARM Holdings."
Shares of Rambus Inc. closed at $11.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Cowen Starts Trillium Therapeutics (TRIL) at Outperform
- UPDATE: Goldman Sachs Upgrades Helmerich & Payne (HP) to Buy
- H.C. Wainwright Starts Stemline Therapeutics (STML) at Buy
Create E-mail Alert Related CategoriesAnalyst Comments, Hot New Coverage, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!